133095-99-5

Basic information

• Product Name: (2S,5S)-2-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-5-(2,3,4-trimethoxy-phenyl)-tetrahydro-furan
• CAS NO: 133095-99-5
• Molecular Weight: 480.579
• Mol File: 133095-99-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,5S)-2-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-5-(2,3,4-trimethoxy-phenyl)-tetrahydro-furan(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,5S)-2-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-5-(2,3,4-trimethoxy-phenyl)-tetrahydro-furan(133095-99-5)
• EPA Substance Registry System: (2S,5S)-2-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-5-(2,3,4-trimethoxy-phenyl)-tetrahydro-furan(133095-99-5)

Safety Data

• Hazardous Substances Data: 133095-99-5(Hazardous Substances Data)

Upstream product

• 133095-91-7 3,4,5-trimethoxyphenylmagnesium bromide 
• 133095-90-6 (S)-2-Bromo-5-(3-methanesulfonyl-5-methoxy-4-propoxy-phenyl)-tetrahydro-furan 
• 106331-89-9 3-methoxy-4-n-propyloxy-5-iodobenzaldehyde 
• 133095-89-3 tert-Butyl-[(S)-5-(3-methanesulfonyl-5-methoxy-4-propoxy-phenyl)-tetrahydro-furan-2-yloxy]-dimethyl-silane 
• 133095-94-0 (S)-4-Hydroxy-4-(3-iodo-5-methoxy-4-propoxy-phenyl)-butyric acid 
• 133095-95-1 4[3-Methoxy-4-n-propyloxy-5-iodophenyl]-4S-butyrolactone 
• 5438-36-8 5-iodovaniline 
• 133095-97-3 (S)-5-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-tetrahydro-furan-2-ol 
• 133095-92-8 4-(3-Iodo-5-methoxy-4-propoxy-phenyl)-4-oxo-butyric acid tert-butyl ester 
• 133095-96-2 (S)-5-(3-Methoxy-5-methylsulfanyl-4-propoxy-phenyl)-dihydro-furan-2-one 
• 133117-06-3 (S)-5-(3-Methanesulfonyl-5-methoxy-4-propoxy-phenyl)-dihydro-furan-2-one 
• 133095-93-9 (S)-4-Hydroxy-4-(3-iodo-5-methoxy-4-propoxy-phenyl)-butyric acid tert-butyl ester 

Relevant articles and documents

Conversion of a silylated hemiacetal into an α-bromoether using trimethylsilylbromide. Synthesis of platelet activating factor antagonist L-659,989

An efficient synthesis of platelet activating factor antagonist L-659,989 has been achieved in ten steps from commercially available 5-iodovanillin. The key transformation converts a silylated hemi-acetal into an α-bromoether followed by a highly stereose